phase 1_completion
saveSun Yat-sen University Hospital Seven — stiripentol (Phase I Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Colorectal Cancer, Gastric Cancer, Ovarian Cancer, Pancreatic Cancer, Peritoneal Cancer
Data sources
globaldata
Found something off?
drug timeline · 7
- phase 1 completionLife Science OHFC — stiripentol (Phase I Trial Completion)Apr 30, 2026 · 160d ago
- approvalDIACOMIT (STIRIPENTOL) — FDA approvalApr 15, 2026 · 175d ago
- approvalDIACOMIT (STIRIPENTOL) — FDA approvalApr 15, 2026 · 175d ago
- approvalDIACOMIT (STIRIPENTOL) — FDA approvalJul 14, 2022 · 1546d ago
- approvalDIACOMIT (STIRIPENTOL) — FDA approvalJul 14, 2022 · 1546d ago
- approvalDIACOMIT (STIRIPENTOL) — FDA approvalAug 20, 2018 · 2970d ago
- approvalDIACOMIT (STIRIPENTOL) — FDA approvalAug 20, 2018 · 2970d ago
🐶 often sniffed alongside
top 8- drugDIACOMIT26 co-mentions · 8 sources
- tagApproval24 co-mentions · 6 sources
- companyBiocodex12 co-mentions · 6 sources
- tagSmall Molecule12 co-mentions · 6 sources
- tagOncology6 co-mentions · 1 sources
- companyLife Science OHFC1 co-mentions · 1 sources
- companySun Yat-sen University Hospital Seven1 co-mentions · 1 sources
- tagNephrology1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that